FPAS
AEMD icon

Focus Partners Advisor Solutions’s Aethlon Medical AEMD Stock Holding History

Focus Partners Advisor Solutions’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-63
Closed -$29K – 340
2022
Q3 		$29K Buy
+63
New +$54.5K ﹤0.01% 399

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
AFGAS
Allegiance Financial Group Advisory Services Vienna, Virginia $578M AUM 24.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Focus Partners Advisor Solutions's AEMD Position: Q4 2022 in Review

Focus Partners Advisor Solutions sold out of Aethlon Medical (AEMD) in Q4 2022, closing a stake of 63 shares — an estimated $29K sold.

Focus Partners Advisor Solutions first reported a position in AEMD in Q3 2022 and held it in 1 quarter. The position peaked at $29K in Q3 2022. 27 funds tracked by Wall St. Rank hold AEMD as of Q4 2022.

  • Focus Partners Advisor Solutions reported no remaining Aethlon Medical position as of Q4 2022 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 63 Aethlon Medical shares in Q4 2022, an estimated $29K.
  • Focus Partners Advisor Solutions first reported a position in Aethlon Medical in Q3 2022 and held it in 1 quarter.
  • Focus Partners Advisor Solutions's Aethlon Medical position peaked at $29K in Q3 2022.
  • 27 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2022.

Based on Focus Partners Advisor Solutions's 13F filing for Q4 2022, filed 14 Feb 2023.